Nordic Bioproducts Group is a spin-off from Aalto University developing and commercializing smart biotechnologies to redesign cellulose into high-value bioproducts.
Wood based cellulose is currently viewed as high-volume and low-value raw material for single use items like paper and cardboard.
We want to change the way we value our pure nordic fibers and enhance the use of existing raw materials. Nordic Bioproducts Group develops intelligent biotechnologies and circular innovations with economical, environmental and social impact.
Working with e.g. food, pharma, plastics and textile industries we want to create a healthy carbon neutral everyday life for the people, sustainable future for the planet and profit for the businesses.
We develop, produce and commercialize Cellulose Hybrids which are renewable, value-adding components engineered to improve material properties.
We produce them from Micro Crystalline Cellulose (MCC) refined from sustainable and traceable Finnish forest fibres or commercial, industrial and agricultural residues that contain cellulose.
Our Cellulose Hybrids can replace fossil based, unsustainable or harmful components in e.g. food, packaging, plastics and textile industries.
Our Cellulose Hybrids are the ideal building blocks for fully biobased bioplastics and as sustainable value-adding reinforcement for biocomposites.
With our innovations we are helping the paper industry to achieve biobased, biodegradable and recyclable barriers for single-use products and packaging.
From food to pharma, our products can be used as a safe component in a vast range of industrial emulsions to achieve functional rheological properties.
Our patented technology can separate natural fibres from mixed textile waste and upscale them into high quality precursors for new textile fibres.
Our patented production method was originally invented in Aalto University and now Nordic Bioproducts Group is the sole owner of the AaltoCell™ patent portfolio. Currently the rights to sell and produce our technology has been outlicensed globally to our partner Andritz Oy, the world leading pulp and paper technology provider.
AaltoCell™ biotechnology produces in a large industrial scale Micro Crystalline Cellulose (MCC) and new high-value-adding biocomponents from a wide variety of cellulose containing materials.
Our technology is fully ready for implementation, offering a fast-track to markets with sustainable technology and bioproducts.
We are a multidisciplinary team of engineers, chemists, entrepreneurs and designers to secure the impact of our bio-innovations.
Fill in the form below and we will be in touch with you shortly.
If you'd like to contact someone specifically, our emails are email@example.com.